Has Usman Naseer received payments from drug or device companies?

Yes. Drug and device makers reported $7,798 in general payments to Usman Naseer across 71 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Usman Naseer did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Usman Naseer come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Usman Naseer

Hospitalist · Seattle, WANPI 1629573571

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.0%), travel and lodging and grants — rather than concentrated in one kind of arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.4%. 2025 is the largest year on record at $3,691, 9.6 times the $386 reported in 2022. Among hospitalist clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,798in general payments, 2019–2025

Across 71 payments — averaging $109.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Philips North America LLC$2K
Boston Scientific$1K
Abbott$861
Abiomed$793
Medtronic$590
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$553
plus $2K from 18 others

What the payments were for

Grants$1,13014%
Travel & lodging$1,80023%
Food & beverage$4,59859%
Education$2693%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Philips North America LLC	6	$1,588
Boston Scientific	4	$1,469
Abbott	8	$861
Abiomed	10	$793
Medtronic	5	$590
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	8	$553
Acist Medical Systems, Inc.	2	$250
Johnson & Johnson	3	$198
W. L. Gore & Associates, Inc.	2	$180
Actelion Pharmaceuticals US, Inc.	2	$164
Penumbra, Inc.	1	$141
Boehringer Ingelheim	1	$132
Scpharmaceuticals Inc.	1	$124
Shockwave Medical, Inc	1	$115
AstraZeneca	2	$97
Chiesi USA, Inc.	2	$85
Amgen	1	$82
Bayer	3	$78
Alnylam Pharmaceuticals Inc.	2	$77
Kiniksa Pharmaceuticals, Ltd.	1	$69
Heartflow, Inc.	2	$43
Teleflex LLC	1	$40
Novartis	2	$39
Edwards Lifesciences	1	$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

(9520) IGT Devices Undivided$1,546
LifeVest$302
ENSITE$269
Impella$227
GENERAL VASCULAR ACCESS$196
UPTRAVI$150
OPSUMIT$150
CVI SYSTEMS$142
Indigo System$141
JARDIANCE$132
CARDIOMEMS$129
XARELTO$124
FUROSCIX$124
GORE CARDIOFORM Septal Occluder$123
XIENCE SKYPOINT$116
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$115
SYMPLICITY G3$114
Perclose ProStyle$112
HD-IVUS$107

How this compares

$7,798 in reported general payments places this provider in the 95th percentile of 661 hospitalist providers in Washington.

See all hospitalist providers in Washington →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BrilintaTicagrelor	27	$11,560
ClopidogrelClopidogrel Bisulfate	37	$211
Atorvastatin Calcium	26	$83
Losartan Potassium	11	$41

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AstraZenecaBrilinta	$97	$11,56027 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 661 hospitalist providers in Washington.

Other hospitalist in Seattle

James BarnesSeattle$12K
Bryce JohnsonSeattle$4K
Benjamin WolpawSeattle$3K
John van TaunaySeattle$1K
Preetham KumarSeattle$1K
Neha DeshpandeSeattle$1K
Amrit LambaSeattle$884
Danh NgoSeattle$705
Jay BrahmbhattSeattle$700
Andrew WhiteSeattle$695

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →